For example, a DNA-based vaccine based on ErbB2, an epidermal growth factor often highly expressed in some colorectal, pancreatic, endometrial, gastric, and breast cancers, has been tested in mouse models, eliciting a more powerful anti-cancer immune response compared with controls [54]. The gene discussed is ERBB2; the disease is cancer.